Literature DB >> 953897

Letter: Interferon in serum and cerebrospinal fluid in subacute sclerosing panencephalitis.

J H Joncas, L R Robillard, A Boudreault, M Leyritz, B J McLaughlin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 953897      PMCID： PMC1878664     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN： 0008-4409            Impact factor:   8.262


× No keyword cloud information.
  6 in total

1.  Intrathecal administration of interferon in neonatal herpes.

Authors:  E De Clercq; V G Edy; H De Vlieger; R Eeckels; J Desmyter
Journal:  J Pediatr       Date:  1975-05       Impact factor: 4.406

2.  Subacute sclerosing panencephalitis treatment.

Authors:  J L Sever
Journal:  Science       Date:  1972-01-14       Impact factor: 47.728

3.  Subacute sclerosing panencephalitis. Elevated Epstein-Barr virus antibody titers and failure of amantadine therapy.

Authors:  J Joncas; G Geoffroy; B McLaughlin; G Albert; N Lapointe; P David; R Lafontaine; M Granger-Julien
Journal:  J Neurol Sci       Date:  1974-04       Impact factor: 3.181

4.  A micro assay for mouse and human interferon.

Authors:  H Dahl; M Degré
Journal:  Acta Pathol Microbiol Scand B Microbiol Immunol       Date:  1972

5.  Letter: Circulating interferon after transfer-factor therapy.

Authors:  G Emödi; M Just; P Grob
Journal:  Lancet       Date:  1973-12-15       Impact factor: 79.321

6.  Immunological features in a case of subacute sclerosing panencephalitis treated with transfer factor.

Authors:  B Vandvik; S S Froland; H M Hoyeraal; R Stien; M Degré
Journal:  Scand J Immunol       Date:  1973       Impact factor: 3.487
  6 in total
  6 in total

1.  Identification of interferon-resistant subpopulations in several strains of measles virus: positive selection by growth of the virus in brain tissue.

Authors:  D R Carrigan; K K Knox
Journal:  J Virol       Date:  1990-04       Impact factor: 5.103

2.  Intraventricular interferon in a case of subacute sclerosing panencephalitis.

Authors:  A Boiardi; S M Baldini; A Sghirlanzoni; R Mancuso; F Corridori
Journal:  Ital J Neurol Sci       Date:  1987-06

3.  Measles virus neurovirulence and host immunity.

Authors:  Michael Oglesbee; Stefan Niewiesk
Journal:  Future Virol       Date:  2011-01-01       Impact factor: 1.831

4.  Cell type-specific MxA-mediated inhibition of measles virus transcription in human brain cells.

Authors:  S Schneider-Schaulies; J Schneider-Schaulies; A Schuster; M Bayer; J Pavlovic; V ter Meulen
Journal:  J Virol       Date:  1994-11       Impact factor: 5.103

5.  Interferon in cerebrospinal fluid. A marker for viral persistence of canine distemper encephalomyelitis.

Authors:  S C Tsai; B A Summers; M J Appel
Journal:  Arch Virol       Date:  1982       Impact factor: 2.574

6.  Identification of a nonproductive, cell-associated form of measles virus by its resistance to inhibition by recombinant human interferon.

Authors:  D R Carrigan; C M Kabacoff
Journal:  J Virol       Date:  1987-06       Impact factor: 5.103
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.